Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New imaging clues help spot rare brain tumor

NCT ID NCT04103190

Knowledge-focused Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 71 adults with suspected MVNT, a rare non-cancerous brain tumor. Researchers used special MRI scans to find unique patterns that help tell MVNT apart from other brain growths. The goal was to improve diagnosis, not to test a treatment.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

71 people

The number who actually took part.

Started

Dec 2019

Finished

Jul 2025

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patient supported for suspicion of MVNT

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient over 18 years old * Suspicion of MVNT on an MRI: it is considered that it will be necessary at least the 2 major criteria associated with at least 1 minor criterion to enter the definition of suspicion of MVNT: Major criteria: * Multinodular aspect in cluster * High FLAIR hypersignal / T2 Minor criteria: * Absence of mass effect * Hyposignal T1 * Center of the lesion in hypsignal FLAIR or T1 hypersignal * Affiliate or beneficiary of a Social Security scheme * Having received informed information about the study and consenting to participate in the study Exclusion Criteria: * Patient benefiting from a legal protection measure * Pregnant or lactating woman * Contraindication to MRI

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Benign neuronal desease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

multinodular and vacuolating neuronal tumor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Benign neuronal desease

Contacts and locations

Locations

  • CHU Rennes

    Rennes, Rennes, 35033, France

  • CHU de Rouen

    Rouen, Rouen, 76000, France

  • Centre Hospitalier Lyon Sud

    Pierre-Bénite, 69495, France

  • Fondation Adolphe de Rothschild

    Paris, PARIS, 75019, France

  • Groupe Hospitalier Pellegrin

    Bordeaux, Bordeaux, 33076, France

  • Hôpital Laennec

    Saint-Herblain, 44800, France

  • Hôpital Pierre Paul Riquet, CHU Purpan

    Toulouse, Toulouse, 31059, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.